CHRS vs REGN: Which Stock is Better?
Side-by-side comparison of Coherus BioSciences Inc and Regeneron Pharmaceuticals Inc in 2026
CHRS
Coherus BioSciences Inc
—
REGN
Regeneron Pharmaceuticals Inc
$654.27
Key Metrics Comparison
| Metric | CHRS | REGN | Winner |
|---|---|---|---|
| Market Cap | $223.66M | $59.10B | REGN |
| P/E Ratio | N/A | 13.91 | REGN |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze CHRS
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CHRS or REGN a better investment?
Comparing CHRS and REGN: Coherus BioSciences Inc has a market cap of $223.66M while Regeneron Pharmaceuticals Inc has $59.10B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CHRS and REGN?
CHRS (Coherus BioSciences Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CHRS or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CHRS or REGN?
Both CHRS and REGN show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: CHRS or REGN?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: CHRS or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $59.10B compared to $223.66M for CHRS.
Should I buy CHRS or REGN in 2026?
Both CHRS and REGN have investment merit. CHRS trades at $N/A while REGN trades at $654.27. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CHRS and REGN stock?
Key differences: Market Cap ($223.66M vs $59.10B), P/E Ratio (N/A vs 13.9x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy CHRS or REGN in 2026?
The choice between CHRS and REGN depends on your investment goals. REGN shows higher revenue growth (0.0%). REGN has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between CHRS and REGN?
CHRS (Coherus BioSciences Inc) has a market cap of $223.66M, while REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B. REGN is the larger company by market value.